How to Get Low-Dose Naltrexone in Missouri

What Is Low-Dose Naltrexone and Why Is It Prescribed Off-Label?

Naltrexone received FDA approval in 1984 at 50 mg daily for opioid use disorder and later for alcohol dependence. At doses between 1.5 mg and 4.5 mg, the drug behaves differently. It briefly blocks opioid receptors for 4 to 6 hours, triggering an upregulation of endogenous endorphins and enkephalins that may modulate immune function and reduce neuroinflammation.

Younger et al. published the first pilot crossover trial of LDN in fibromyalgia (N=10) in Pain Medicine in 2009, reporting a 30% reduction in symptoms compared to placebo over an 8-week treatment period (1). A follow-up from the same group (N=31) confirmed these findings with statistically significant improvements in pain, fatigue, and overall quality of life (2). Since then, clinical interest has expanded into autoimmune conditions including Crohn's disease, multiple sclerosis, and Hashimoto's thyroiditis.

LDN sits in a regulatory gray area. The compound itself is FDA-approved, but the low-dose formulation is not commercially manufactured. Every LDN prescription in Missouri must be filled by a compounding pharmacy that prepares the capsule from bulk naltrexone powder. This is legal, well-established, and the primary pathway patients across the United States use to access the medication.

Missouri's Telehealth and Prescribing Rules for LDN

Missouri permits licensed healthcare providers to prescribe LDN via telehealth without requiring an in-person visit first. This is the fastest route for most patients.

Under Missouri Revised Statutes Section 191.1145, telehealth encounters are treated equivalently to in-person visits for prescribing purposes, provided the provider establishes a legitimate provider-patient relationship during the encounter. The Missouri Board of Registration for the Healing Arts does not maintain a specific exclusion for off-label naltrexone prescriptions delivered via telemedicine.

Three categories of prescriber can write an LDN prescription in Missouri. MDs and DOs have full independent prescribing authority. Nurse practitioners (NPs) in Missouri operate under a collaborative practice arrangement with a physician, and they can prescribe LDN as long as the collaborative agreement covers the relevant drug class. Physician assistants (PAs) prescribe under their supervising physician's authority and face no additional restriction on compounded naltrexone.

A typical telehealth LDN consultation takes 15 to 30 minutes. The provider reviews your medical history, confirms there are no contraindications (active opioid use being the primary one), and electronically sends the prescription to your chosen compounding pharmacy. Some telehealth platforms specializing in LDN can complete this process within 24 to 48 hours.

Which Compounding Pharmacies in Missouri Fill LDN Prescriptions?

Missouri-licensed 503A compounding pharmacies can legally prepare and dispense LDN capsules. Out-of-state 503A pharmacies with appropriate non-resident pharmacy licenses can also ship to Missouri addresses.

Section 503A of the Federal Food, Drug, and Cosmetic Act permits pharmacies to compound medications based on individual patient prescriptions. These pharmacies source pharmaceutical-grade naltrexone hydrochloride powder and compound it into capsules at the specific dose your provider prescribes. Most patients start at 1.5 mg and titrate to 4.5 mg over 2 to 4 weeks.

Several compounding pharmacies in Missouri's major metropolitan areas (St. Louis, Kansas City, Springfield, Columbia) routinely fill LDN prescriptions. National compounding pharmacies such as Belmar Pharmacy, Skip's Pharmacy, and AgelessRx Pharmacy also ship to Missouri. When selecting a pharmacy, verify that it holds current Missouri Board of Pharmacy licensure and follows United States Pharmacopeia (USP) Chapter 795 standards for non-sterile compounding.

Pricing for a 30-day supply of LDN capsules typically ranges from $30 to $60 without insurance. Some pharmacies offer 90-day supplies at a per-month discount. Because LDN is compounded, pricing is not standardized across pharmacies, so comparing quotes from two or three pharmacies before filling your prescription is worth the effort.

According to the Missouri Board of Pharmacy, there are over 200 licensed compounding pharmacies in the state. Not all of them routinely stock naltrexone powder, so calling ahead or having your provider confirm availability before sending the prescription saves time.

What Labs Should You Get Before Starting LDN?

A baseline liver function panel (AST, ALT, bilirubin) is the standard pre-prescribing lab for LDN. Most providers also request a complete blood count.

Naltrexone carries an FDA black-box warning for hepatotoxicity at the full 50 mg dose. At doses of 4.5 mg or below, liver injury has not been reported in published clinical trials. The Younger et al. pilot trial monitored liver enzymes throughout the study period and found no elevations (1). A 2014 review in Experimental Biology and Medicine covering multiple LDN studies noted zero cases of hepatotoxicity at low doses (3).

Still, the standard of care calls for a baseline liver panel. If AST or ALT levels exceed three times the upper limit of normal, most clinicians will defer LDN initiation until the underlying cause is identified and treated. Patients with known hepatic impairment may require closer monitoring, though the extremely low dose provides a wide safety margin.

Some providers request additional labs depending on the indication. For autoimmune patients, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) can serve as baseline inflammatory markers to track treatment response. For thyroid patients, a TSH and free T4 help establish a starting point. These are not universally required for LDN itself but are part of good clinical practice for the conditions LDN may be treating.

Missouri Quest Diagnostics and Labcorp locations both offer the relevant panels, and many telehealth LDN providers can order labs electronically that you complete at a local draw site before your consultation.

Missouri Medicaid and Insurance Coverage for LDN

Missouri Medicaid (MO HealthNet) does not cover low-dose naltrexone for off-label indications such as fibromyalgia, chronic inflammation, or autoimmune conditions. Coverage is limited to the FDA-approved 50 mg formulation for substance use disorders.

This is consistent with most state Medicaid programs. Because LDN is compounded at a non-standard dose for off-label indications, payers generally classify it as an uncovered compounded medication. Private insurers in Missouri follow similar policies. A 2022 survey by the LDN Research Trust found that fewer than 5% of patients surveyed reported successful insurance reimbursement for compounded LDN.

The practical impact is manageable. At $30 to $60 per month out of pocket, LDN is among the least expensive specialty medications patients encounter. For comparison, pregabalin (Lyrica), a commonly prescribed fibromyalgia drug, carries a brand-name cost exceeding $500 per month without insurance, and generic gabapentin at therapeutic doses typically runs $15 to $45 per month.

If your provider prescribes LDN and you want to attempt insurance coverage, a prior authorization request is technically possible. Documentation typically requires a letter of medical necessity from the prescribing clinician, clinical notes supporting the off-label indication, and evidence of failure on at least one FDA-approved therapy for the condition being treated. Success rates for these appeals remain low.

Health savings accounts (HSAs) and flexible spending accounts (FSAs) can be used to pay for compounded LDN prescriptions, as the medication is prescribed by a licensed provider for a medical condition.

Clinical Evidence Supporting LDN Use

The evidence base for LDN is growing, though it remains concentrated in small trials and observational studies. Three conditions have the most published data: fibromyalgia, Crohn's disease, and multiple sclerosis.

Fibromyalgia. The Stanford group led by Jarred Younger published two trials. The 2009 pilot (N=10) used a crossover design and showed a 30% symptom reduction with LDN 4.5 mg versus placebo (1). The 2013 follow-up (N=31) was a double-blind, placebo-controlled trial that reported significantly greater reductions in fibromyalgia pain (28.8% reduction vs. 18.0% on placebo, P=0.016) (2). Dr. Younger stated in that publication: "The results suggest that low-dose naltrexone has a specific and clinically beneficial impact on fibromyalgia pain."

Crohn's disease. Jill Smith at Penn State published a pilot trial (N=17) in 2007 showing that 89% of patients responded to LDN 4.5 mg and 67% achieved clinical remission at 12 weeks (4). A subsequent double-blind RCT (N=40) confirmed a significantly higher remission rate with LDN compared to placebo (5). Endoscopic improvement was documented in the treatment group, suggesting a mucosal healing effect beyond symptom control alone.

Multiple sclerosis. A 2010 crossover trial (N=60) published in Annals of Neurology examined LDN in primary progressive MS and found significant improvement in mental health quality of life scores, though physical measures did not reach significance (6).

The proposed mechanism of action involves transient opioid receptor blockade leading to compensatory upregulation of endogenous opioid peptides (beta-endorphin, met-enkephalin) and modulation of Toll-like receptor 4 (TLR4) signaling on microglia and macrophages. A 2018 review in Pharmacological Reviews described this dual mechanism as the leading hypothesis for LDN's anti-inflammatory effects (7).

Larger randomized controlled trials are needed. The National Institutes of Health has listed LDN-related studies on ClinicalTrials.gov, and several are actively recruiting as of 2026.

Step-by-Step Process to Get LDN in Missouri

Getting an LDN prescription in Missouri follows a predictable sequence. Most patients complete the process within 3 to 7 days from initial consultation to receiving their medication.

Step 1: Choose a prescriber. Select either a local Missouri physician familiar with LDN or a telehealth provider licensed in Missouri. Telehealth platforms that specialize in LDN consultations typically have the shortest wait times.

Step 2: Complete pre-visit labs. Get a liver function panel (AST, ALT, total bilirubin) and CBC drawn at a local lab. Results usually return within 24 to 48 hours. Some providers will order labs after the initial visit, but having them ready speeds up the process.

Step 3: Attend the consultation. During a 15- to 30-minute visit, your provider will review your medical history, current medications, and lab results. They will confirm that you are not currently taking opioid medications (LDN is contraindicated within 7 to 14 days of opioid use). If appropriate, they will prescribe LDN, typically starting at 1.5 mg nightly.

Step 4: Select a compounding pharmacy. Your provider sends the prescription to a Missouri-licensed 503A compounding pharmacy of your choice. If you prefer a national compounding pharmacy, confirm it holds a Missouri non-resident pharmacy license.

Step 5: Receive your medication. Local pharmacies may have your prescription ready within 1 to 3 business days. Shipped prescriptions from out-of-state pharmacies typically arrive within 3 to 5 business days.

Step 6: Titrate the dose. Most providers start patients at 1.5 mg for the first 1 to 2 weeks, then increase to 3.0 mg, and finally to the target dose of 4.5 mg. This gradual titration reduces the likelihood of vivid dreams and mild insomnia, the two most commonly reported side effects.

Transferring an LDN Prescription to Missouri

If you already have an active LDN prescription from another state, Missouri allows prescription transfers between pharmacies. The process requires your current pharmacy to communicate directly with your new Missouri compounding pharmacy.

Because LDN is not a controlled substance at the state level in Missouri (naltrexone is unscheduled), the transfer process is simpler than it would be for Schedule II through V medications. Call your new Missouri compounding pharmacy, provide the name and phone number of your current pharmacy, and the pharmacists will handle the transfer.

One practical consideration: if your prescriber is not licensed in Missouri, you will need to establish care with a Missouri-licensed provider for ongoing refills. Telehealth makes this straightforward, and most LDN-focused telehealth services can onboard existing patients quickly with a brief chart review rather than a full initial consultation.

Side Effects and Safety Monitoring

LDN is well tolerated at doses of 1.5 mg to 4.5 mg. The most commonly reported side effects are vivid dreams (reported by approximately 37% of patients in the Younger 2013 trial) and transient sleep disturbance during the first 1 to 2 weeks (2).

Other reported effects include mild headache, nausea, and transient anxiety. These typically resolve within the first week of treatment or after dose adjustment. Serious adverse events have not been reported in any published LDN trial at doses of 4.5 mg or below.

Dr. Jill Smith noted in her 2011 Crohn's disease trial: "No serious adverse events were attributed to low-dose naltrexone, and no patient withdrew from the study due to side effects" (5).

Follow-up visits are generally recommended at 4 to 6 weeks after initiation and then every 3 to 6 months. Repeat liver function testing at the 3-month mark is a common practice, though evidence of hepatotoxicity at low doses is absent from the published literature.

Patients taking immunosuppressive medications should discuss potential interactions with their provider. LDN's immune-modulating properties could theoretically alter the effect of drugs like methotrexate or azathioprine, though this interaction has not been formally studied in controlled trials.